Amiodarone induced phospholipidosis biochemical, morphological and functional changes in the lungs of rats chronically treated with amiodarone
- 1 October 1987
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (19) , 3209-3214
- https://doi.org/10.1016/0006-2952(87)90635-6
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Role of phospholipase A inhibition in amiodarone pulmonary toxicity in ratsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Side effects and complications of amiodarone therapyAmerican Heart Journal, 1985
- Amiodarone Hepatotoxicity Simulating Alcoholic Liver DiseaseNew England Journal of Medicine, 1984
- Amiodarone pharmacokineticsAmerican Heart Journal, 1983
- Relationships between amiodarone dosage, drug concentrations, and adverse side effectsAmerican Heart Journal, 1983
- Amiodarone pulmonary toxicityAmerican Heart Journal, 1983
- Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug.Circulation, 1982
- Control of refractory life-threatening ventricular tachyarrhythmias by amiodaroneAmerican Heart Journal, 1981
- Clinical pharmacology and therapeutic applications of the antiarrhythmic agent, amiodaroneAmerican Heart Journal, 1981
- Plasma Total Lipid, Cholesterol, Triglycerides, Phospholipids and Free Fatty Acids in a Healthy Scandinavian PopulationActa Medica Scandinavica, 1961